This is the authors' abstract. We don't add key points for this paper.
A chemical foundation for function-oriented studies of pectenotoxin 2 (PTX2) is described. A synthesis of the bicyclic GH-system, and the design and synthesis of a PTX2-analogue, is presented. While maintaining critical features for actin binding, and lacking the Achilles' heel for the natural product's anticancer activity (the AB-spiroketal), this first-generation analogue did not possess the anticancer properties of PTX2, an observation that indicates the molecular significance of features present in the natural product's CDEF-tetracycle.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
O’Rourke et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: